International Medical Research Frontier

Objective To investigate the therapeutic efficacy of ureteroscopic lithotripsy in managing ureteral stone patients. Methods This study enrolled 50 ureteral stone patients treated at our hospital between July 2022 and July 2025. Patients were randomly assigned into two groups using a random number table: the observation group (30 cases) received ureteral stent placement followed by ureteroscopic lithotripsy, while the control group (20 cases) underwent ureteroscopic lithotripsy alone. Clinical outcomes were compared between the two groups. Results The observation group demonstrated shorter operative time and higher treatment costs (P<0.05). There was no significant difference in hospitalization duration between groups (P>0.05). The observation group showed higher success rates and stone clearance rates compared to the control group (P<0.05). Postoperative VAS scores were significantly lower in the observation group at 2h,6h, and 12h (P<0.05), but no difference was observed at 24h (P>0.05). No significant difference in complication rates was found between groups (P>0.05). Conclusion Ureteroscopic lithotripsy with preoperative stent placement, while increasing treatment costs, demonstrates significant therapeutic advantages. It improves surgical efficiency and success rates, ensures effective stone removal, reduces postoperative pain, and maintains low complication risks, highlighting its clinical benefits.

Ureteroscopic lithotripsy; Ureteral stones; Ureter